Showing results (531-540 of 1,363) with videos related to

Sort By:
Pageof 137
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|August 24, 2010
Determination of polyadipates migrating from lid gaskets of glass jars. Hydrolysis to adipic acid and measurement by LC-MS/MSM Driffield, E L Bradley, N Harmer, et al.
Health Policy and Planning|June 4, 2009
The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS controlRegien G Biesma, Ruairí Brugha, Andrew Harmer, et al.
Channels (Austin, Tex.)|May 15, 2026
Quantitative analysis of trafficking defects induced by heterozygous expression of hERG voltage sensor domain variantsYihong Zhang, Joseph Carr, Jules C Hancox, et al.
Inorganic Chemistry|March 25, 2024
Macrocyclic Copper(II) Complexes as Catalysts for Electrochemically Mediated Atom TransferMasnun Naher, Chuyi Su, Jeffrey R Harmer, et al.
Musculoskeletal Science & Practice|December 28, 2023
Improving musculoskeletal physiotherapists' confidence in patient-centred care informed by acceptance and commitment therapy: A descriptive studyMarie K March, Belinda Judd, Alison R Harmer, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2022
Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistanceChristopher J Harmer, Francois Lebreton, Jason Stam, et al.
Journal of Behavior Therapy and Experimental Psychiatry|April 18, 2016
Assessment of automatic associations with bodily sensations and agoraphobic situations in panic disorderMarcella L Woud, Eni S Becker, Mike Rinck, et al.
Biochemistry|January 21, 2004
The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinityNicholas J Harmer, Luca Pellegrini, Dima Chirgadze, et al.
The British Journal of Radiology|July 27, 2000
False positive 131I whole body scans in thyroid cancerG Mitchell, B E Pratt, L Vini, et al.
The Lancet. Diabetes & Endocrinology|December 4, 2018
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trialHakim-Moulay Dehbi, Ujjal Mallick, Jonathan Wadsley, et al.
Pageof 137